title: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.
authors.forename: T P
authors.initials: TP
authors.lastname: Graham
authors.forename: J T
authors.initials: JT
authors.lastname: Bricker
authors.forename: F W
authors.initials: FW
authors.lastname: James
authors.forename: W B
authors.initials: WB
authors.lastname: Strong
mesh_terms: D001017:Aortic Coarctation / Q000175:diagnosis; D003330:Coronary Vessel Anomalies / Q000175:diagnosis; D004374:Ductus Arteriosus, Patent / Q000175:diagnosis; D004437:Ebstein Anomaly / Q000175:diagnosis; D004608:Eligibility Determination; D006330:Heart Defects, Congenital / Q000175:diagnosis* / Q000601:surgery; D006343:Heart Septal Defects / Q000175:diagnosis; D006349:Heart Valve Diseases / Q000151:congenital / Q000175:diagnosis; D006801:Humans; D008382:Marfan Syndrome / Q000175:diagnosis; D013177:Sports; D013178:Sports Medicine; D013771:Tetralogy of Fallot / Q000175:diagnosis; D014188:Transposition of Great Vessels / Q000175:diagnosis